See Editorial on Page 1671
Steatohepatitis/Metabolic Liver Disease
IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice
Version of Record online: 27 MAR 2014
Copyright © 2014 The Authors. HEPATOLOGY published by Wiley on behalf of the American Association for the Study of Liver Diseases.
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Volume 59, Issue 5, pages 1830–1839, May 2014
How to Cite
Harley, I. T.W., Stankiewicz, T. E., Giles, D. A., Softic, S., Flick, L. M., Cappelletti, M., Sheridan, R., Xanthakos, S. A., Steinbrecher, K. A., Sartor, R. B., Kohli, R., Karp, C. L. and Divanovic, S. (2014), IL-17 signaling accelerates the progression of nonalcoholic fatty liver disease in mice. Hepatology, 59: 1830–1839. doi: 10.1002/hep.26746
Potential conflict of interest: Nothing to report.
Supported by an R01 DK099222, a Pilot Grant under NIH P30 DK078392, and a CCHMC Trustee Grant (to SD). I.T.W.H. received funding from NIH grants AI075159, HD07463, GM063483, and a Fellowship from the Albert J. Ryan Foundation. Gnotobiotic mice were supported by P40 OD010995, P30 DK34987 and the Crohn's and Colitis Foundation of America.
- Issue online: 23 APR 2014
- Version of Record online: 27 MAR 2014
- Accepted manuscript online: 2 OCT 2013 06:08PM EST
- Manuscript Accepted: 2 SEP 2013
- Manuscript Received: 14 MAY 2013
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.